On Human Disease-Causing Amino Acid Variants: Statistical Study of Sequence and Structural Patterns
TLDR
Analysis of thermodynamics data reported in the literature indicated that disease‐causing variants tend to destabilize proteins and their interactions, which prompted us to investigate the effects of amino acid mutations on large databases of experimentally measured energy changes in unrelated proteins.Abstract:
Statistical analysis was carried out on large set of naturally occurring human amino acid variations, and it was demonstrated that there is a preference for some amino acid substitutions to be associated with diseases. At an amino acid sequence level, it was shown that the disease-causing variants frequently involve drastic changes in amino acid physicochemical properties of proteins such as charge, hydrophobicity, and geometry. Structural analysis of variants involved in diseases and being frequently observed in human population showed similar trends: disease-causing variants tend to cause more changes in hydrogen bond network and salt bridges as compared with harmless amino acid mutations. Analysis of thermodynamics data reported in the literature, both experimental and computational, indicated that disease-causing variants tend to destabilize proteins and their interactions, which prompted us to investigate the effects of amino acid mutations on large databases of experimentally measured energy changes in unrelated proteins. Although the experimental datasets were linked neither to diseases nor exclusory to human proteins, the observed trends were the same: amino acid mutations tend to destabilize proteins and their interactions. Having in mind that structural and thermodynamics properties are interrelated, it is pointed out that any large change in any of them is anticipated to cause a disease.read more
Citations
More filters
Journal ArticleDOI
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Song,Maarja-Liisa Nairismagi,Yurike Laurensia,Jing Quan Lim,Jing Tan,Zhi Mei Li,Wan Lu Pang,Atish Kizhakeyil,Giovani Claresta Wijaya,Dachuan Huang,Sanjanaa Nagarajan,Burton Kuan Hui Chia,Daryl Ming Zhe Cheah,Yan Hui Liu,Fen Zhang,Hui Lan Rao,Tiffany Tang,Esther Kam Yin Wong,Jin Xin Bei,Jabed Iqbal,Jabed Iqbal,Nicholas Francis Grigoropoulos,Siok Bian Ng,Wee Joo Chng,Bin Tean Teh,Soo Yong Tan,Navin Kumar Verma,Hao Fan,Hao Fan,Soon Thye Lim,Choon Kiat Ong +30 more
TL;DR: It is demonstrated that STAT3 activation confers high PD-L1 expression, which may promote tumor immune evasion and the combination of PD-1/PD-L 1 antibodies and STAT3 inhibitors might be a promising therapeutic approach for NKTL, and possibly PTCL.
Journal ArticleDOI
SKEMPI 2.0: an updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation.
Justina Jankauskaite,Brian Jiménez-García,Justas Dapkunas,Juan Fernández-Recio,Juan Fernández-Recio,Iain H. Moal +5 more
TL;DR: This version now contains manually curated binding data for 7085 mutations, an increase of 133%, including changes in kinetics for 1844 mutations, enthalpy and entropy changes for 443 mutations, and 440 mutations, which abolish detectable binding.
Journal ArticleDOI
The Contribution of Missense Mutations in Core and Rim Residues of Protein–Protein Interfaces to Human Disease
TL;DR: This study demonstrated the different distribution and properties of disease-causing SAVs and polymorphisms within different structural regions and in relation to the energetic contribution of amino acid in protein–protein interfaces, thus highlighting the importance of a structural system biology approach for predicting the effect of S AVs.
Journal ArticleDOI
Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.
TL;DR: Among the many thematic overviews of precision oncology, this review innovates by further comprehensively including precision pharmacology, and within this framework, articulating its protein structural landscape and consequences to cellular signaling pathways.
Journal ArticleDOI
mutation3D: cancer gene prediction through atomic clustering of coding variants in the structural proteome
Michael J. Meyer,Ryan Lapcevic,Alfonso E. Romero,Mark Yoon,Jishnu Das,Juan Felipe Beltran,Matthew Mort,Peter D. Stenson,David Neil Cooper,Alberto Paccanaro,Haiyuan Yu +10 more
TL;DR: It is shown that clustering with mutation3D is able to separate functional from nonfunctional mutations by analyzing a combination of 8,869 known inherited disease mutations and 2,004 SNPs overlaid together upon the same sets of crystal structures and homology models.
References
More filters
Journal ArticleDOI
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features
Wolfgang Kabsch,Chris Sander +1 more
TL;DR: A set of simple and physically motivated criteria for secondary structure, programmed as a pattern‐recognition process of hydrogen‐bonded and geometrical features extracted from x‐ray coordinates is developed.
Journal ArticleDOI
MutationTaster evaluates disease-causing potential of sequence alterations
TL;DR: MutationTaster allows the efficient filtering of NGS data for alterations with high disease-causing potential and provides Perl scripts that can process data from all major platforms (Roche 454, Illumina Genome Analyzer and ABI SOLiD).
Journal ArticleDOI
The FoldX web server: an online force field
TL;DR: The core functionality of FoldX, namely the calculation of the free energy of a macromolecule based on its high-resolution 3D structure, is now publicly available through a web server at FoldX.
Journal ArticleDOI
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
TL;DR: The development of small molecules that irreversibly bind to a common oncogenic mutant, K-Ras(G12C) and structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner are provided.
Journal ArticleDOI
I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure.
TL;DR: I-Mutant2.0 is introduced as a unique and valuable helper for protein design, even when the protein structure is not yet known with atomic resolution.